$30.00
Price
$1.5B
Market Cap
—
P/E Ratio
-8.6
Forward P/E
$-3.55
EPS (TTM)
—
Dividend Yield
$373M
Cash
$14000
Total Debt
49M
Shares Out
$17.00
$35.83
52-Week Range
Institutional Ownership of Arrivent Biopharma Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Arrivent Biopharma Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q4 | |||||
| SELL | EXIT | — | — | $20.58 | |
| 2025-Q2 | |||||
| BUY | NEW | 421.3K | $9M | $20.81 | |
Insider Trading for Arrivent Biopharma Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.